Location: Field-Based, Netherlands
Reporting to: General Manager, Nordic & Benelux
Orchard Therapeutics, a Kyowa Kirin company, is a global gene therapy leader focused on transforming the lives of patients with rare disorders through innovative gene therapies based on gene-modified hematopoietic stem cells (HSCs). Orchard has its global headquarters in London, England, and its U.S. headquarters in Boston, Massachusetts.
Job Summary:
Reporting to the General Manager, Nordic & Benelux, the Therapeutic Operations Lead will be responsible for delivering the company’s commercial business in neurometabolic disorders. This will include building trusted relationships with qualified treatment centers, healthcare professionals and patient organizations with the aim of promoting early identification and access to treatment of eligible patients in Benelux and to identify new opportunities to grow the company’s pipeline.
This is a unique opportunity to contribute to the rapid growth and success of a leading biotechnology company with a transformative technology.
Key elements and responsibilities, including but not limited to:
· Develop trusted relationships with qualified treatment centers (QTC’s), healthcare professionals and patient organizations
· Supporting the QTC in Utrecht, The Netherland and coordinating patient’s treatment ensuring that it adheres to what is described in the Product Manual and facilitating the exchange of the related mandatory documentation with Orchard’s Supply Chain Team
· In partnership with the Medical Director, engage disease experts via advisory boards and individual interactions to accelerate patient identification and diagnosis
· Oversee the development of disease-related and product-related materials and their approval for use in the Benelux, in partnership with the Medical Director
· Drive disease awareness and the identification of potential patient candidates for treatment with Libmeldy® and other Orchard gene therapies
· Resolve issues of access to treatment by potential patient candidates to gene therapy, in collaboration with the Market Access function
· Plan activities and track budget in the franchise
· Role-model corporate values and behaviours; foster compliance with legal and regulatory requirements and corporate SOPs, and the pursuit of the highest ethical standards
· Performs other tasks and assignments as needed and specified by management. regarding the strategy and operations in the neurometabolic franchise
· Represent Orchard during meetings and congresses.
Apply on company website Amsterdam, North Holland, Netherlands Remote (Country) Full-time
Orchard Therapeutics is hiring a Therapeutic Operations Lead - Benelux
About company
Orchard was founded in 2015—but our roots run deeper, going back to some of the first research and clinical development involving hematopoietic stem cell, or HSC, gene therapy. Our team has played a central role in the evolution of this technology from a promising idea to a potentially life-transforming reality.
Today, we carry forward our history of visionary science to imagine new possibilities for people and families affected by genetic and other severe diseases. We’re building on decades of research to apply our HSC gene therapy platform to areas of significant medical need where we believe it may have distinct therapeutic advantages.
Orchard has acquired advanced gene therapy programs, including Strimvelis® and Libmeldy™, and continues to develop transformative treatments for rare inherited diseases such as metachromatic leukodystrophy (MLD), Wiskott Aldrich syndrome (WAS), and beta thalassemia.